Harmony Biosciences: Stock Dips After FDA Rejects Pitolisant Application for Treatment of Sleep Disorder

FDA Issues Refusal to File for Harmony Biosciences’ Pitolisant for Idiopathic Hypersomnia On Wednesday, Harmony Biosciences Holdings, Inc. (HRMY) received a setback in its quest to bring pitolisant, an investigational therapy for excessive daytime sleepiness (EDS) in adult patients with idiopathic hypersomnia (IH), to the market. The U.S. Food and Drug Administration (FDA) issued a…

Read More

“Get Ready to High-Five: HAFNIA LIMITED’s Share Buyback Program is Making Moves!”

Let’s Talk about Hafnia’s Share Repurchase Program What’s the Buzz? So, you may have heard about Hafnia Limited’s recent announcement regarding their program to repurchase up to 18,000,000 of the company’s shares in open market transactions. It’s definitely been making waves in the finance world, with investors and analysts alike keeping a close eye on…

Read More

Unlocking the Potential: A Look at Ethereum’s Price Forecast of $12,000

The Ethereum Price Breakout: A Positive Sign for Investors Understanding the Ethereum Price Movement The Ethereum price is currently showing signs of a breakout, which has caught the attention of many investors and analysts in the cryptocurrency market. An analyst recently identified the formation of an inverse head and shoulder pattern on Ethereum’s 6-month long-term…

Read More

Iovance’s Surprisingly Generous Stock Options: A Humorous Look at Their Inducement Grants Report

Iovance’s New CCO Gets a Warm Welcome with Stock Options and RSUs In a recent press release, Iovance Biotherapeutics, a leading biotech company specializing in polyclonal Tumor Infiltrating Lymphocyte (TIL) therapies for cancer patients, welcomed their new Chief Commercial Officer (CCO), Daniel Kirby, with open arms and a generous stock package. This announcement was made…

Read More

Reminder from Faruqi & Faruqi: Don’t Forget About the Crocs Class Action Lawsuit! Deadline’s March 24, 2025

Attention Investors: Considering a Claim Against Crocs? Reach Out to Faruqi & Faruqi, LLP Investing in the stock market can be a thrilling yet challenging experience. Sometimes, even the most carefully chosen investments can lead to unexpected losses. If you’ve recently suffered significant financial damages due to Crocs Inc. (CRC) stocks, you’re not alone. Securities…

Read More

“Universal Stainless Joins Forces with Aperam: A Milestone Acquisition in the Steel Industry”

Universal Stainless & Alloy Products, Inc. Acquired by Aperam S.A. BRIDGEVILLE, Pa., Jan. 23, 2025 (GLOBE NEWSWIRE) — Universal Stainless & Alloy Products, Inc. (“Universal” or the “Company”) today announced the completion of its previously-announced acquisition by Aperam S.A. (the “Acquisition”), pursuant to which Universal stockholders are entitled to receive $45.00 per share of Universal’s…

Read More

Silver Price Prediction: Bear Market Ahead? Why XAG/USD Dropped Towards $32 – A Fun and Friendly Take

Silver Prices Plummet: A Mysterious Dip Amidst Falling Bond Yields and Stable Dollar In an intriguing turn of events, silver prices took a nosedive on Monday, dipping over 1.20%, despite a drop in US Treasury bond yields and the Greenback posting minuscule gains. Let’s delve deeper into this silver slump and explore the underlying factors….

Read More